nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—HTR1D—meninx—malignant glioma	0.0724	0.107	CbGeAlD
Yohimbine—HTR1B—dura mater—malignant glioma	0.0688	0.101	CbGeAlD
Yohimbine—HTR1D—dura mater—malignant glioma	0.0666	0.0981	CbGeAlD
Yohimbine—HTR2C—choroid plexus—malignant glioma	0.0561	0.0826	CbGeAlD
Yohimbine—DRD3—telencephalic ventricle—malignant glioma	0.0295	0.0435	CbGeAlD
Yohimbine—HTR2A—choroid plexus—malignant glioma	0.0281	0.0415	CbGeAlD
Yohimbine—HTR1B—telencephalic ventricle—malignant glioma	0.0171	0.0252	CbGeAlD
Yohimbine—HTR1D—telencephalic ventricle—malignant glioma	0.0166	0.0244	CbGeAlD
Yohimbine—HTR2C—telencephalic ventricle—malignant glioma	0.0164	0.0242	CbGeAlD
Yohimbine—HTR2A—cerebellar cortex—malignant glioma	0.0142	0.0209	CbGeAlD
Yohimbine—HTR1A—telencephalic ventricle—malignant glioma	0.0138	0.0204	CbGeAlD
Yohimbine—DRD2—telencephalic ventricle—malignant glioma	0.0125	0.0184	CbGeAlD
Yohimbine—HTR1F—telencephalon—malignant glioma	0.01	0.0148	CbGeAlD
Yohimbine—HTR2A—pons—malignant glioma	0.01	0.0148	CbGeAlD
Yohimbine—HTR2A—vertebral column—malignant glioma	0.00994	0.0146	CbGeAlD
Yohimbine—HTR1B—blood vessel—malignant glioma	0.00848	0.0125	CbGeAlD
Yohimbine—HTR2A—telencephalic ventricle—malignant glioma	0.00824	0.0121	CbGeAlD
Yohimbine—HTR1D—blood vessel—malignant glioma	0.00821	0.0121	CbGeAlD
Yohimbine—HTR2A—pineal body—malignant glioma	0.00715	0.0105	CbGeAlD
Yohimbine—HTR1F—central nervous system—malignant glioma	0.00571	0.00841	CbGeAlD
Yohimbine—ADRA1D—telencephalon—malignant glioma	0.00533	0.00785	CbGeAlD
Yohimbine—HTR1B—brainstem—malignant glioma	0.00464	0.00683	CbGeAlD
Yohimbine—HTR1F—brain—malignant glioma	0.00453	0.00668	CbGeAlD
Yohimbine—HTR1D—brainstem—malignant glioma	0.00449	0.00661	CbGeAlD
Yohimbine—HTR2C—brainstem—malignant glioma	0.00445	0.00655	CbGeAlD
Yohimbine—HTR2A—endothelium—malignant glioma	0.00442	0.00652	CbGeAlD
Yohimbine—SLC6A4—brainstem—malignant glioma	0.00422	0.00621	CbGeAlD
Yohimbine—HTR1B—telencephalon—malignant glioma	0.00412	0.00606	CbGeAlD
Yohimbine—HTR2A—blood vessel—malignant glioma	0.00408	0.00601	CbGeAlD
Yohimbine—DRD3—central nervous system—malignant glioma	0.00403	0.00594	CbGeAlD
Yohimbine—HTR1D—telencephalon—malignant glioma	0.00399	0.00587	CbGeAlD
Yohimbine—HTR2C—telencephalon—malignant glioma	0.00395	0.00581	CbGeAlD
Yohimbine—HTR1A—brainstem—malignant glioma	0.00374	0.00551	CbGeAlD
Yohimbine—SLC6A4—telencephalon—malignant glioma	0.00374	0.00551	CbGeAlD
Yohimbine—HTR2B—telencephalon—malignant glioma	0.00371	0.00546	CbGeAlD
Yohimbine—DRD2—brainstem—malignant glioma	0.00338	0.00498	CbGeAlD
Yohimbine—HTR1A—telencephalon—malignant glioma	0.00332	0.00489	CbGeAlD
Yohimbine—DRD2—retina—malignant glioma	0.00326	0.00481	CbGeAlD
Yohimbine—DRD3—brain—malignant glioma	0.0032	0.00472	CbGeAlD
Yohimbine—HTR2C—medulla oblongata—malignant glioma	0.0031	0.00457	CbGeAlD
Yohimbine—ADRA1B—central nervous system—malignant glioma	0.0031	0.00456	CbGeAlD
Yohimbine—ADRA1D—central nervous system—malignant glioma	0.00303	0.00446	CbGeAlD
Yohimbine—DRD2—telencephalon—malignant glioma	0.003	0.00442	CbGeAlD
Yohimbine—HTR1B—midbrain—malignant glioma	0.00296	0.00435	CbGeAlD
Yohimbine—ADRA2C—telencephalon—malignant glioma	0.00292	0.0043	CbGeAlD
Yohimbine—HTR1B—spinal cord—malignant glioma	0.00288	0.00425	CbGeAlD
Yohimbine—HTR1D—midbrain—malignant glioma	0.00286	0.00422	CbGeAlD
Yohimbine—HTR2C—midbrain—malignant glioma	0.00283	0.00417	CbGeAlD
Yohimbine—HTR2C—spinal cord—malignant glioma	0.00276	0.00407	CbGeAlD
Yohimbine—SLC6A4—midbrain—malignant glioma	0.00269	0.00396	CbGeAlD
Yohimbine—SLC6A4—spinal cord—malignant glioma	0.00262	0.00386	CbGeAlD
Yohimbine—ADRA1B—brain—malignant glioma	0.00246	0.00362	CbGeAlD
Yohimbine—HTR2A—embryo—malignant glioma	0.00243	0.00359	CbGeAlD
Yohimbine—ADRA1D—brain—malignant glioma	0.00241	0.00354	CbGeAlD
Yohimbine—HTR1A—midbrain—malignant glioma	0.00239	0.00351	CbGeAlD
Yohimbine—HTR1B—central nervous system—malignant glioma	0.00234	0.00345	CbGeAlD
Yohimbine—ADRA2A—telencephalon—malignant glioma	0.00233	0.00343	CbGeAlD
Yohimbine—HTR1A—spinal cord—malignant glioma	0.00233	0.00343	CbGeAlD
Yohimbine—ADRA2C—medulla oblongata—malignant glioma	0.00229	0.00338	CbGeAlD
Yohimbine—HTR1D—central nervous system—malignant glioma	0.00227	0.00334	CbGeAlD
Yohimbine—HTR2C—central nervous system—malignant glioma	0.00224	0.0033	CbGeAlD
Yohimbine—HTR2A—brainstem—malignant glioma	0.00223	0.00329	CbGeAlD
Yohimbine—DRD2—midbrain—malignant glioma	0.00216	0.00317	CbGeAlD
Yohimbine—HTR2A—retina—malignant glioma	0.00215	0.00317	CbGeAlD
Yohimbine—SLC6A4—central nervous system—malignant glioma	0.00213	0.00313	CbGeAlD
Yohimbine—HTR2B—central nervous system—malignant glioma	0.00211	0.0031	CbGeAlD
Yohimbine—ADRA2C—midbrain—malignant glioma	0.0021	0.00309	CbGeAlD
Yohimbine—ADRA2C—spinal cord—malignant glioma	0.00204	0.00301	CbGeAlD
Yohimbine—CYP2D6—brainstem—malignant glioma	0.00203	0.00299	CbGeAlD
Yohimbine—HTR2A—telencephalon—malignant glioma	0.00198	0.00292	CbGeAlD
Yohimbine—HTR1A—central nervous system—malignant glioma	0.00189	0.00278	CbGeAlD
Yohimbine—HTR1B—brain—malignant glioma	0.00186	0.00274	CbGeAlD
Yohimbine—HTR1A—cerebellum—malignant glioma	0.00185	0.00272	CbGeAlD
Yohimbine—ADRA2A—medulla oblongata—malignant glioma	0.00183	0.00269	CbGeAlD
Yohimbine—CYP2D6—telencephalon—malignant glioma	0.0018	0.00266	CbGeAlD
Yohimbine—HTR1D—brain—malignant glioma	0.0018	0.00265	CbGeAlD
Yohimbine—HTR2C—brain—malignant glioma	0.00178	0.00262	CbGeAlD
Yohimbine—DRD2—central nervous system—malignant glioma	0.00171	0.00251	CbGeAlD
Yohimbine—SLC6A4—brain—malignant glioma	0.00169	0.00249	CbGeAlD
Yohimbine—HTR2B—brain—malignant glioma	0.00167	0.00246	CbGeAlD
Yohimbine—ADRA2A—midbrain—malignant glioma	0.00167	0.00246	CbGeAlD
Yohimbine—DRD2—cerebellum—malignant glioma	0.00167	0.00246	CbGeAlD
Yohimbine—ADRA2C—central nervous system—malignant glioma	0.00166	0.00244	CbGeAlD
Yohimbine—ADRA2A—spinal cord—malignant glioma	0.00163	0.0024	CbGeAlD
Yohimbine—ADRA2C—cerebellum—malignant glioma	0.00162	0.00239	CbGeAlD
Yohimbine—HTR2A—medulla oblongata—malignant glioma	0.00156	0.00229	CbGeAlD
Yohimbine—HTR1A—brain—malignant glioma	0.0015	0.00221	CbGeAlD
Yohimbine—HTR2A—midbrain—malignant glioma	0.00142	0.00209	CbGeAlD
Yohimbine—HTR2A—spinal cord—malignant glioma	0.00139	0.00204	CbGeAlD
Yohimbine—DRD2—brain—malignant glioma	0.00135	0.00199	CbGeAlD
Yohimbine—ADRA2A—central nervous system—malignant glioma	0.00132	0.00195	CbGeAlD
Yohimbine—ADRA2C—brain—malignant glioma	0.00132	0.00194	CbGeAlD
Yohimbine—ADRA2A—cerebellum—malignant glioma	0.00129	0.00191	CbGeAlD
Yohimbine—HTR2A—central nervous system—malignant glioma	0.00113	0.00166	CbGeAlD
Yohimbine—HTR2A—cerebellum—malignant glioma	0.0011	0.00162	CbGeAlD
Yohimbine—ADRA2A—brain—malignant glioma	0.00105	0.00155	CbGeAlD
Yohimbine—CYP3A4—central nervous system—malignant glioma	0.00104	0.00153	CbGeAlD
Yohimbine—CYP2D6—central nervous system—malignant glioma	0.00103	0.00151	CbGeAlD
Yohimbine—CYP2D6—cerebellum—malignant glioma	0.001	0.00148	CbGeAlD
Yohimbine—HTR2A—brain—malignant glioma	0.000893	0.00132	CbGeAlD
Yohimbine—CYP2D6—brain—malignant glioma	0.000814	0.0012	CbGeAlD
Yohimbine—HTR1A—Signaling Pathways—MDM2—malignant glioma	2.77e-05	8.63e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CD80—malignant glioma	2.77e-05	8.63e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	2.77e-05	8.63e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	2.77e-05	8.62e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APC—malignant glioma	2.77e-05	8.62e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	2.77e-05	8.62e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—VEGFA—malignant glioma	2.76e-05	8.61e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—RAF1—malignant glioma	2.76e-05	8.6e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MDM2—malignant glioma	2.76e-05	8.59e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—RAF1—malignant glioma	2.75e-05	8.56e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—STAT3—malignant glioma	2.74e-05	8.52e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EGF—malignant glioma	2.73e-05	8.52e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ERBB2—malignant glioma	2.73e-05	8.51e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	2.72e-05	8.47e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	2.72e-05	8.46e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	2.72e-05	8.46e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	2.7e-05	8.4e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PTEN—malignant glioma	2.7e-05	8.4e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	2.69e-05	8.39e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	2.69e-05	8.38e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MMP9—malignant glioma	2.69e-05	8.38e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MMP9—malignant glioma	2.69e-05	8.38e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	2.68e-05	8.36e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	2.68e-05	8.36e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MDM2—malignant glioma	2.68e-05	8.35e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PTEN—malignant glioma	2.67e-05	8.33e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PTEN—malignant glioma	2.67e-05	8.33e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	2.67e-05	8.33e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RAF1—malignant glioma	2.67e-05	8.32e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—KRAS—malignant glioma	2.66e-05	8.28e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	2.65e-05	8.25e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.65e-05	8.25e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	2.64e-05	8.24e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MDM2—malignant glioma	2.64e-05	8.22e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RAF1—malignant glioma	2.63e-05	8.19e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	2.62e-05	8.15e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	2.61e-05	8.13e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—AKT1—malignant glioma	2.61e-05	8.12e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	2.61e-05	8.12e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	2.6e-05	8.11e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—FGF2—malignant glioma	2.6e-05	8.1e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—BRAF—malignant glioma	2.6e-05	8.1e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MYC—malignant glioma	2.6e-05	8.09e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—BCHE—malignant glioma	2.6e-05	8.09e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	2.6e-05	8.08e-05	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	2.59e-05	8.08e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CXCL8—malignant glioma	2.59e-05	8.07e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	2.58e-05	8.03e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—STAT3—malignant glioma	2.57e-05	8e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CASP3—malignant glioma	2.57e-05	8e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	2.57e-05	8e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL2—malignant glioma	2.57e-05	7.99e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.56e-05	7.99e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—FGF2—malignant glioma	2.56e-05	7.97e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MYC—malignant glioma	2.54e-05	7.92e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—EGFR—malignant glioma	2.54e-05	7.91e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PIK3CB—malignant glioma	2.54e-05	7.9e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	2.53e-05	7.88e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	2.52e-05	7.85e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTGS2—malignant glioma	2.51e-05	7.82e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	2.51e-05	7.81e-05	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	2.5e-05	7.8e-05	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	2.49e-05	7.76e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—EGFR—malignant glioma	2.49e-05	7.74e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CASP3—malignant glioma	2.48e-05	7.73e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL2—malignant glioma	2.48e-05	7.71e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	2.47e-05	7.69e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CASP3—malignant glioma	2.47e-05	7.69e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL2—malignant glioma	2.46e-05	7.67e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	2.44e-05	7.61e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MDM2—malignant glioma	2.43e-05	7.58e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	2.43e-05	7.57e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	2.43e-05	7.56e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RAF1—malignant glioma	2.43e-05	7.55e-05	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	2.42e-05	7.55e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—VEGFA—malignant glioma	2.42e-05	7.52e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	2.42e-05	7.52e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	2.41e-05	7.52e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.41e-05	7.5e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	2.4e-05	7.49e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	2.4e-05	7.48e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ERBB2—malignant glioma	2.4e-05	7.47e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—KRAS—malignant glioma	2.4e-05	7.47e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL2—malignant glioma	2.4e-05	7.46e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MDM2—malignant glioma	2.39e-05	7.46e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—STAT3—malignant glioma	2.39e-05	7.45e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—STAT3—malignant glioma	2.39e-05	7.45e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MYC—malignant glioma	2.39e-05	7.44e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RAF1—malignant glioma	2.39e-05	7.43e-05	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	2.38e-05	7.43e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	2.38e-05	7.42e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	2.37e-05	7.37e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CAV1—malignant glioma	2.37e-05	7.37e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	2.36e-05	7.36e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.36e-05	7.35e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL2—malignant glioma	2.36e-05	7.35e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	2.36e-05	7.34e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—KRAS—malignant glioma	2.35e-05	7.32e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MMP9—malignant glioma	2.34e-05	7.3e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EGFR—malignant glioma	2.34e-05	7.28e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MMP9—malignant glioma	2.33e-05	7.26e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PTEN—malignant glioma	2.33e-05	7.26e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.33e-05	7.26e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	2.33e-05	7.25e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.32e-05	7.22e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CXCL8—malignant glioma	2.28e-05	7.09e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	2.27e-05	7.08e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	2.27e-05	7.06e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.26e-05	7.04e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	2.26e-05	7.02e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.24e-05	6.97e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	2.23e-05	6.95e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MYC—malignant glioma	2.22e-05	6.92e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MYC—malignant glioma	2.22e-05	6.92e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	2.22e-05	6.91e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—KRAS—malignant glioma	2.21e-05	6.87e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	2.2e-05	6.86e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	2.2e-05	6.85e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	2.2e-05	6.85e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTEN—malignant glioma	2.19e-05	6.82e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	2.19e-05	6.81e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	2.18e-05	6.79e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	2.18e-05	6.79e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CASP3—malignant glioma	2.18e-05	6.78e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL2—malignant glioma	2.17e-05	6.77e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	2.17e-05	6.77e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EGFR—malignant glioma	2.17e-05	6.77e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	2.17e-05	6.76e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	2.17e-05	6.74e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.16e-05	6.74e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	2.16e-05	6.72e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	2.16e-05	6.72e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.16e-05	6.71e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2.15e-05	6.69e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.14e-05	6.67e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.14e-05	6.66e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—malignant glioma	2.13e-05	6.64e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	2.12e-05	6.6e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	2.11e-05	6.56e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.09e-05	6.52e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—malignant glioma	2.09e-05	6.5e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—STAT3—malignant glioma	2.08e-05	6.49e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PPARG—malignant glioma	2.08e-05	6.48e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.07e-05	6.46e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.07e-05	6.43e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.06e-05	6.41e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—KRAS—malignant glioma	2.05e-05	6.39e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	2.05e-05	6.39e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.05e-05	6.37e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	2.04e-05	6.34e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	2.04e-05	6.34e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	2.03e-05	6.31e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.03e-05	6.31e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	2.02e-05	6.28e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.01e-05	6.27e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CAT—malignant glioma	2.01e-05	6.26e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MYC—malignant glioma	2.01e-05	6.25e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	2e-05	6.24e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2e-05	6.22e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	1.98e-05	6.18e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.97e-05	6.13e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	1.96e-05	6.12e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	1.96e-05	6.11e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—malignant glioma	1.96e-05	6.11e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.95e-05	6.07e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.95e-05	6.06e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MYC—malignant glioma	1.94e-05	6.03e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MYC—malignant glioma	1.93e-05	6e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PIK3CA—malignant glioma	1.9e-05	5.93e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.9e-05	5.91e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.9e-05	5.9e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.89e-05	5.9e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	1.89e-05	5.88e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	1.89e-05	5.88e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EGFR—malignant glioma	1.88e-05	5.87e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MYC—malignant glioma	1.87e-05	5.84e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	1.85e-05	5.77e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—malignant glioma	1.85e-05	5.76e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MYC—malignant glioma	1.84e-05	5.74e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.84e-05	5.74e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	1.83e-05	5.71e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.83e-05	5.7e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—STAT3—malignant glioma	1.83e-05	5.7e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—malignant glioma	1.83e-05	5.68e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—malignant glioma	1.83e-05	5.68e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.82e-05	5.66e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	1.8e-05	5.62e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—AKT1—malignant glioma	1.8e-05	5.61e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.8e-05	5.61e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.79e-05	5.57e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.79e-05	5.57e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—KRAS—malignant glioma	1.78e-05	5.54e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—AKT1—malignant glioma	1.76e-05	5.49e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	1.73e-05	5.39e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	1.7e-05	5.31e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	1.7e-05	5.3e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MYC—malignant glioma	1.7e-05	5.3e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MYC—malignant glioma	1.67e-05	5.21e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EGFR—malignant glioma	1.66e-05	5.18e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—AKT1—malignant glioma	1.66e-05	5.16e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.65e-05	5.15e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.65e-05	5.14e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—malignant glioma	1.65e-05	5.13e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.64e-05	5.12e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.64e-05	5.1e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.64e-05	5.1e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.64e-05	5.1e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.64e-05	5.09e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	1.59e-05	4.95e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—malignant glioma	1.59e-05	4.95e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—malignant glioma	1.58e-05	4.93e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—KRAS—malignant glioma	1.57e-05	4.89e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.57e-05	4.88e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—AKT1—malignant glioma	1.55e-05	4.84e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CAV1—malignant glioma	1.55e-05	4.82e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.55e-05	4.81e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.55e-05	4.81e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—AKT1—malignant glioma	1.54e-05	4.8e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	1.54e-05	4.8e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—malignant glioma	1.54e-05	4.79e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.52e-05	4.74e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.51e-05	4.72e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.49e-05	4.64e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.44e-05	4.5e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTEN—malignant glioma	1.43e-05	4.45e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.42e-05	4.42e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.41e-05	4.39e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.41e-05	4.38e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—malignant glioma	1.4e-05	4.35e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	1.39e-05	4.33e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.37e-05	4.28e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PPARG—malignant glioma	1.36e-05	4.24e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.34e-05	4.18e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.34e-05	4.16e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	1.3e-05	4.05e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.29e-05	4.02e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.28e-05	3.98e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—AKT1—malignant glioma	1.26e-05	3.93e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.25e-05	3.89e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.24e-05	3.86e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.18e-05	3.67e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.16e-05	3.61e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.08e-05	3.36e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.07e-05	3.33e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.06e-05	3.29e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.01e-05	3.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTEN—malignant glioma	9.33e-06	2.91e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—AKT1—malignant glioma	8.23e-06	2.56e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.58e-06	2.05e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—AKT1—malignant glioma	5.38e-06	1.68e-05	CbGpPWpGaD
